Trial Profile
Phase II trial of RAD001 [everolimus] in patients with refractory colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2007
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Oct 2006 New trial record.